secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001493152-25-006285
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology raises $1.05M in registered direct offering and private placement
--------------------------------------------------------------------------------

- Issued 434,784 shares at $2.415/share and warrants for 434,784 shares at $2.29/share.
- Warrants are immediately exercisable for a five-year term; gross proceeds ~$1.05M.
- Offering closed on Feb 13, 2025; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent with 7.5% cash fee and warrants.
- Private placement warrants and underlying shares unregistered, resale registration to be filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225006285/0001493152-25-006285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225006285/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer